Literature DB >> 19319944

Demographic and risk factors in patients with head and neck tumors.

Ruth Tachezy1, Jan Klozar, Linda Rubenstein, Elaine Smith, Martina Saláková, Jana Smahelová, Viera Ludvíková, Eliska Rotnáglová, Roman Kodet, Eva Hamsíková.   

Abstract

The association between human papillomavirus (HPV) infection and the development of head and neck cancer has been documented recently. In this study on 86 head and neck cancer patients and 124 controls, data regarding demographics, behavioral risk factors, and risks related to HPV exposure were collected. HPV detection was carried out using polymerase chain reaction in the tumors and in oral exfoliated cells, and HPV typing by a reverse line blot assay specific for 37 HPV types. Sera were tested by an enzyme-linked immunosorbent assay specific for HPV proteins. Head and neck cancer cases report significantly more oral-anal contact (P = 0.02) and tobacco and alcohol use than controls (P = 0.001; P = 0.02, respectively). High-risk HPV DNA was detected in 43% of oral washings of cases and 4% of controls (P < 0.0001). The association between the presence of high-risk HPV DNA in oral exfoliated cells and in tumor tissues was statistically significant (adjusted P < 0.0001). The prevalence of HPV-specific antibodies was significantly higher in cases than in controls (adjusted P < 0.0001). These results provide epidemiological and immunological evidence for HR HPV as a strong risk factor (OR = 44.3, P < 0.0001) for head and neck cancer, even after controlling for age, tobacco and alcohol use. The detection of high-risk HPV DNA in oral exfoliated cells and HPV-specific antibodies in serum can be considered as clinically relevant surrogate markers for the presence of a HPV-associated head and neck cancer, with a high sensitivity (83%) and specificity (88%). Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319944     DOI: 10.1002/jmv.21470

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  30 in total

Review 1.  HPV-associated head and neck cancer: a virus-related cancer epidemic.

Authors:  Shanthi Marur; Gypsyamber D'Souza; William H Westra; Arlene A Forastiere
Journal:  Lancet Oncol       Date:  2010-05-05       Impact factor: 41.316

Review 2.  The role of HPV in head and neck cancer and review of the HPV vaccine.

Authors:  Gypsyamber D'Souza; Amanda Dempsey
Journal:  Prev Med       Date:  2011-10       Impact factor: 4.018

Review 3.  Epidemiology and clinical aspects of HPV in head and neck cancers.

Authors:  Anil K Chaturvedi
Journal:  Head Neck Pathol       Date:  2012-07-03

Review 4.  Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.

Authors:  Jan Klozar; Ruth Tachezy; Eliška Rotnáglová; Eva Košlabová; Martina Saláková; Eva Hamšíková
Journal:  Wien Med Wochenschr       Date:  2010-06

Review 5.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

6.  Immunophenotyping of HPV Types 16 and 18 among Sudanese Patients with Oral Lesions.

Authors:  Ibrahim A M Ginawi; Ebtihag A Mahgoub; Hussain G Ahmed
Journal:  Oman Med J       Date:  2012-05

Review 7.  Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.

Authors:  Sarah M Tiggelaar; Margaret J Lin; Raphael P Viscidi; Jia Ji; Jennifer S Smith
Journal:  J Adolesc Health       Date:  2012-02       Impact factor: 5.012

Review 8.  Human Papilloma Virus (HPV) in head and neck region: review of literature.

Authors:  L Mannarini; V Kratochvil; L Calabrese; L Gomes Silva; P Morbini; J Betka; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-06       Impact factor: 2.124

9.  Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis.

Authors:  Sanjana Balachandra; Samuel B Kusin; Rebecca Lee; James-Michael Blackwell; Jasmin A Tiro; Lindsay G Cowell; Cheng-Ming Chiang; Shwu-Yuan Wu; Sanskriti Varma; Erika L Rivera; Helen G Mayo; Lianghao Ding; Baran D Sumer; Jayanthi S Lea; Aditya Bagrodia; Linda M Farkas; Richard Wang; Carole Fakhry; Kristina R Dahlstrom; Erich M Sturgis; Andrew T Day
Journal:  Cancer       Date:  2020-12-03       Impact factor: 6.860

10.  Modifiable risk behaviors in patients with head and neck cancer.

Authors:  Janani Sivasithamparam; Carly A Visk; Ezra E W Cohen; Andrea C King
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.